Framework agreement for the purchase of Skyclarys (omaveloxolone)

This tender seeks to establish a framework agreement for the procurement of the medicinal product Skyclarys (omaveloxolone). The primary objective is to supply hospital pharmacies of Amgros' stakeholders with this specific drug. Additionally, the Capital Region's hospital pharmacy will procure Skyclarys for resale to Greenland and the Faroe Islands. This implies a need for a reliable and continuous supply of this medication, likely for a specific patient population or treatment protocol. The framework agreement will likely set terms and conditions for future orders, including pricing, delivery, and quality assurance, over a defined period. Amgros, as the procuring entity, is responsible for coordinating the procurement for multiple regional hospital pharmacies, ensuring efficient access to essential medicines across its associated regions and territories.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Denmark, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.